Conversely, the pharmacological inhibition of ACSS2 using Compound 1 (10 μM) substantially abrogated oncoVV-AVL-induced autophagy (Figure 4E) and concurrently attenuated lipid accumulation in HCC cells (Figure 4F,G). The gene discussed is ACSS2; the disease is hepatocellular carcinoma.